Discover the emerging class of degrader-antibody conjugates – a modality that is drawing increasing interest from biotech ...

There has been a swing towards in vivo CAR-T therapies lately, as big pharmas sign acquisition deals and new therapies hit ...

Single-cell analysis is reshaping drug discovery, but interpretation remains slow. AI single cell approaches may close the ...

Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...

AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.

Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.

Discover some of the new atopic dermatitis treatments in clinical development that could overcome existing challenges in the ...

Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.

Last week, GSK agreed to acquire Canadian biotech 35Pharma for $950 million, adding a new pulmonary hypertension program to its respiratory and cardiopulmonary pipeline. The deal is built around HS235 ...

Pfizer reaffirmed it is a household name through its partnership with BioNTech on the Pfizer-BioNTech COVID-19 vaccine, which received its first U.S. authorization from the Food and Drug ...